Chemoradiotherapy‐induced increase in Th17 cell frequency in cervical cancer patients is associated with therapy resistance and early relapse

Cervical cancer therapy is still a major clinical challenge, as patients substantially differ in their response to standard treatments, including chemoradiotherapy (CRT). During cervical carcinogenesis, T‐helper (Th)‐17 cells accumulate in the peripheral blood and tumor tissues of cancer patients an...

Descripción completa

Detalles Bibliográficos
Autores principales: Theobald, Laura, Stroeder, Russalina, Melchior, Patrick, Iordache, Ioan Iulian, Tänzer, Tanja, Port, Meike, Glombitza, Birgit, Marx, Stefanie, Schub, David, Herr, Christian, Hart, Martin, Ludwig, Nicole, Meese, Eckart, Kim, Yoo‐Jin, Bohle, Rainer Maria, Smola, Sigrun, Rübe, Christian, Solomayer, Erich Franz, Walch‐Rückheim, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637579/
https://www.ncbi.nlm.nih.gov/pubmed/34469022
http://dx.doi.org/10.1002/1878-0261.13095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637579/
https://www.ncbi.nlm.nih.gov/pubmed/34469022
http://dx.doi.org/10.1002/1878-0261.13095

Ejemplares similares